Oncology Information Systems Market Size and Forecast
The Oncology Information Systems Market will reach US$ 3.20 billion in 2026, up from US$ 2.94 billion in 2025, and is projected to reach US$ 6.84 billion by 2035, registering strong growth at a CAGR of 8.8% during the forecast period from 2026 to 2035.
Oncology information systems (OIS) manage data on cancer patient hospitalization programs, treatment deliveries, plans, and diagnostic results.
The global Oncology Information Systems (OIS) market is experiencing significant growth due to the increasing cancer incidence, adoption of advanced healthcare IT solutions, and demand for integrated cancer care. OIS helps healthcare providers manage cancer treatment workflows, patient scheduling, and electronic medical records. However, challenges like high implementation costs, data security concerns, and skilled professionals in developing regions may hinder market expansion.
North America currently dominates the market due to its advanced healthcare infrastructure, while the Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare investments and cancer prevalence.
For more details on this report, Request for Sample
Oncology Information Systems Market Scope
| Metrics | Details | |
| CAGR | 8.8% | |
| Market Size Available for Years | 2022-2035 | |
| Estimation Forecast Period | 2025-2035 | |
| Revenue Units | Value (US$ Bn) | |
| Segments Covered | Product & Services | Software, Services |
| Application | Radiation Oncology, Medical Oncology, Surgical Oncology | |
| End User | Hospitals & Diagnostic Imaging Centers, Government Institutions, Ambulatory Surgical Centers, Research Facilities | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and the Middle East & Africa | |
Key Takeaways
- North America accounted for approximately 42.3% of the global market share in 2024, driven by advanced healthcare IT infrastructure, increasing cancer prevalence, and widespread adoption of precision oncology technologies.
- Software solutions contribute approximately 54.5% of total market revenue, owing to growing demand for centralized oncology data management, treatment planning, and real-time patient monitoring capabilities.
- Radiation oncology applications collectively account for more than 35% of market demand, supported by increasing adoption of image-guided radiotherapy and AI-assisted treatment planning technologies.
- Hospitals and cancer treatment centers represent over 60% of end-user adoption, leveraging integrated oncology information systems to streamline workflows and improve clinical outcomes.
- AI-enabled oncology information platforms are witnessing annual adoption growth exceeding 15%, driven by increasing demand for predictive analytics, clinical decision support, and personalized cancer care solutions.
- Asia-Pacific is projected to register the fastest growth, with a CAGR of approximately 18.5% during the forecast period, supported by expanding healthcare digitalization initiatives and increasing investments in cancer care infrastructure.
- Cloud-based oncology information systems are increasingly improving interoperability, treatment coordination, and remote patient management capabilities across healthcare ecosystems.
- Strategic collaborations among healthcare technology providers, oncology centers, and software developers are accelerating innovation and commercialization globally.
- Growing investments in precision oncology, AI-powered treatment planning, laboratory integration technologies, and digital healthcare platforms are expected to drive long-term market expansion.
Oncology Information Systems Market Dynamics: Drivers & Restraints
Driver: Increasing Prevalence of Cancer Worldwide
The global cancer incidence is driving the growth of the oncology information systems (OIS) market. With millions of new cancer cases diagnosed annually, healthcare systems need efficient, technology-driven solutions. OIS platforms streamline patient data management, facilitate accurate treatment planning, and enable real-time monitoring, contributing to the expansion of the global OIS market.
For instance, as per the International Agency for Research on Cancer, globally, nearly 20 Billion incident cases were reported in 2022. In 2030, nearly 24.10 Billion cases and in 2040, nearly 29.90 Billion cases were expected.
Hence, the rise in cancer incidence helps the healthcare providers face pressure to deliver timely, accurate, and personalized treatment. OIS platforms manage large patient data, support complex treatment planning, and improve workflow efficiency. The growing patient load requires scalable digital solutions to coordinate care across departments and specialists. This trend is accelerating OIS adoption in hospitals, oncology centers, and research institutions, contributing to global market expansion.
Restraint: Data Security and Privacy Concerns
The global oncology information systems market faces challenges in data security and patient privacy due to the growing adoption of cloud-based solutions and stringent data protection regulations. Ensuring end-to-end encryption, secure user authentication, and system interoperability presents technical and operational challenges, potentially slowing market growth in regions with limited cybersecurity infrastructure or regulatory clarity.
Oncology Information Systems Market Segment Analysis
The global oncology information systems market is segmented based on product & services, application, end user, and region.
Product & Services:
The software segment of the product & services is expected to hold 54.5% in the oncology information Systems market
The software segment in the oncology information systems market is experiencing significant growth due to the need for centralized data management, improved treatment planning, and real-time patient monitoring. The rise in cancer incidence is driving healthcare providers to adopt advanced digital tools for efficient clinical workflows and improved patient outcomes.
The shift towards value-based care and personalized medicine has increased demand for integrated software systems for data-driven decision-making and tailored treatment protocols. Technological advancements in AI, cloud computing, and big data analytics are enhancing oncology software's capabilities.
For instance, in May 2204, GE HealthCare unveiled Revolution RT, a new radiation therapy CT solution with innovative hardware and software, aiming to increase imaging accuracy and simplify simulation workflow. The AI-enhanced Intelligent Radiation Therapy platform interfaces with the Spectronic MRI Planner.
Oncology Information Systems Market Geographical Analysis
North America dominated the global oncology information systems market with the highest share of 42.3% in 2024
North America dominates the global oncology information systems market due to advanced healthcare infrastructure, high IT adoption, and significant cancer research investments. The region benefits from EHR integration and interoperability policies. The growing number of cancer cases and focus on precision medicine in the U.S. and Canada encourage healthcare providers to adopt robust OIS platforms. Key market players, technological advancements, and favorable reimbursement scenarios further accelerate the market's growth.
For instance, the American Cancer Society predicts that by 2025, the US will experience 2,041,910 new cancer cases and 618,120 deaths, based on data from central cancer registries and the National Center for Health Statistics. This data is based on population-based cancer occurrence and outcomes.
Asia-Pacific region in the global oncology information systems market is expected to grow with the highest CAGR of 18.5% in the forecast period of 2025 to 2033
The Asia Pacific region is experiencing rapid growth in the oncology information systems market due to rising cancer prevalence, healthcare expenditure, and awareness of advanced technologies. Countries like China, India, and Japan are investing in digital healthcare infrastructure to improve care delivery and patient outcomes. Government initiatives, electronic health records, and telemedicine are driving demand for integrated systems. The rising burden of cancer cases in densely populated areas prompts hospitals to streamline workflows using comprehensive information systems for efficient patient data management and outcome monitoring.
For instance, in September 2024, the Indian Cancer Genome Atlas (ICGA) launched India's first comprehensive cancer multi-omics data portal, offering open access to clinically correlated data from Indian cancer patients, aiming to transform cancer research and treatment.
Market Drivers, Restraints, Opportunities, and Challenges (DROC Analysis)
The Oncology Information Systems Market is driven by increasing cancer prevalence worldwide, rising adoption of healthcare IT solutions, and growing demand for personalized cancer treatment approaches. Oncology information systems provide healthcare providers with comprehensive solutions for patient data management, treatment planning, workflow optimization, and outcome monitoring. However, high implementation costs, interoperability challenges, cybersecurity concerns, and regulatory compliance requirements may restrain market growth. Significant opportunities are emerging through AI-enabled clinical decision support systems, cloud-based healthcare platforms, digital pathology integration, and advanced analytics solutions designed to improve operational efficiency and patient outcomes across oncology care settings.
Technology Landscape & Future Trends
Technological advancements are transforming the Oncology Information Systems Market through artificial intelligence, cloud computing technologies, digital twin applications, and multimodal oncology data integration platforms. Manufacturers are increasingly developing intelligent oncology ecosystems capable of supporting predictive treatment planning, genomic data analysis, and real-time clinical decision-making. Future trends include AI-assisted oncology workflows, integrated electronic health record platforms, cloud-enabled precision medicine solutions, and multimodal cancer data analytics designed to enhance treatment personalization and healthcare delivery efficiency. Emerging technologies are expected to significantly improve interoperability, scalability, and accessibility across global oncology care ecosystems.
Oncology Information Systems Market Key Players
The major global players in the oncology information systems market include Koninklijke Philips N.V., Varian Medical Systems, McKesson Corporation, Elekta AB, Epic Systems Corporation, IBM, Cerner Corporation, Advanced Data Systems, and Bogardus Medical Systems, Inc., among others.
Recent Developments:
- June 2026: Koninklijke Philips N.V. expanded its AI-enabled oncology informatics capabilities by enhancing integrated imaging and cancer care workflow solutions that support precision oncology and multidisciplinary treatment planning.
- June 2026: IBM Corporation strengthened its healthcare AI portfolio by advancing hybrid cloud and data management technologies designed to improve oncology data integration and clinical decision support systems.
- May 2026: Varian Medical Systems (Siemens Healthineers) continued advancing its oncology software platforms by enhancing radiotherapy planning and oncology information management solutions for cancer care providers.
- May 2026: Epic Systems Corporation expanded interoperability capabilities across its electronic health record platform to improve oncology care coordination, treatment tracking, and patient engagement initiatives.
- April 2026: Elekta AB strengthened its oncology informatics portfolio by advancing digital solutions that support radiation oncology workflows, treatment planning, and real-time patient data management.
- April 2026: McKesson Corporation continued expanding its oncology technology offerings through solutions that improve clinical workflow efficiency, practice management, and value-based cancer care delivery.
- March 2026: Oracle Health (formerly Cerner Corporation) enhanced its cloud-based healthcare technologies by expanding oncology-related data management and clinical information capabilities across healthcare systems.
- March 2026: Advanced Data Systems Corporation continued investing in healthcare information management solutions that support clinical documentation, workflow automation, and specialty care practices.
- February 2026: Bogardus Medical Systems, Inc. strengthened its oncology information system offerings by focusing on customised software solutions designed for radiation oncology departments and cancer treatment centers.
Who Should Buy This Report?
This report is designed for healthcare IT companies, oncology information system developers, hospitals and cancer treatment centers, pharmaceutical companies, diagnostic laboratories, radiation oncology providers, biotechnology firms, clinical research organizations (CROs), healthcare consulting organizations, government healthcare agencies, academic and research institutions, institutional investors, private equity firms, digital health solution providers, and market intelligence companies. It provides valuable insights for stakeholders seeking to identify growth opportunities, strengthen digital oncology strategies, evaluate investment prospects, and make informed business decisions across the global oncology information systems ecosystem.
Why Should You Buy This Report?
This report provides comprehensive market size estimates and forecasts through 2033, helping organizations identify high-growth opportunities across oncology software platforms, radiation oncology management systems, precision medicine applications, and AI-enabled healthcare technologies. It delivers detailed analysis of market drivers, restraints, opportunities, and challenges, along with regional and country-level trends supporting strategic planning. The report offers competitive intelligence covering company strategies, partnerships, acquisitions, technological developments, product innovations, and regulatory initiatives. It also analyzes emerging technologies including cloud-based oncology information platforms, AI-powered clinical decision support systems, multimodal oncology data integration solutions, and digital treatment planning technologies. Additionally, it supports investment planning, business expansion, competitive benchmarking, and market entry strategies while helping organizations capitalize on the rapidly evolving global oncology information systems industry.
